Northwest Biotherapeutics Inc
NWBO
Market Cap$386.95M
Close$
$-0.13
143.6% downside
Current Fair Value
143.6% downsideOvervalued by 143.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $386.95 Million |
|---|---|
| Enterprise Value | $435.29 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.06 |
| Beta | -0.59 |
| Outstanding Shares | 1,214,316,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.07 |
|---|---|
| PEG | -21.43 |
| Price to Sales | - |
| Price to Book Ratio | -0.31 |
| Enterprise Value to Revenue | 264.61 |
| Enterprise Value to EBIT | -6.95 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | -0.89 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Northwest Biotherapeutics Inc
CEO: Linda Powers